After stopping oxycodone, how long should I wait before starting Suboxone (buprenorphine/naloxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wait 6-12 Hours After Last Oxycodone Dose Before Starting Suboxone

You must wait until mild to moderate withdrawal symptoms appear before initiating Suboxone, which typically occurs 6-12 hours after stopping short-acting opioids like oxycodone. Starting Suboxone too early will precipitate severe withdrawal due to buprenorphine's high receptor affinity displacing oxycodone from opioid receptors 1, 2.

Timing Based on Oxycodone Pharmacology

Oxycodone has a half-life of 3-4 hours, and withdrawal symptoms begin 2-3 half-lives after the last dose 2. This translates to:

  • 6-12 hours for immediate-release oxycodone
  • Symptoms peak at 48-72 hours
  • Resolution occurs within 7-14 days

Critical Requirement: Objective Withdrawal Must Be Present

Do not initiate Suboxone based on time alone—you must document objective withdrawal signs. Use the Clinical Opiate Withdrawal Scale (COWS) to assess 2:

  • Elevated pulse (>80 bpm)
  • Pupil dilation (mydriasis)
  • Sweating, lacrimation, rhinorrhea
  • Restlessness, yawning
  • GI symptoms (cramping, nausea)
  • Piloerection, tremor

Target COWS score: Mild withdrawal (score ≥8-12) before first Suboxone dose.

Suboxone Initiation Protocol

Once withdrawal is confirmed 1:

  1. First dose: 2-4 mg buprenorphine/naloxone
  2. Repeat dosing: Additional 2-4 mg every 2 hours if tolerated, until withdrawal symptoms resolve
  3. Day 1 total: Typically 4-8 mg needed
  4. Day 2: Reassess and adjust; this becomes the maintenance dose
  5. For pain management (not addiction): Divide total daily dose into 3-4 administrations

Common Pitfall: Precipitated Withdrawal

The most critical error is starting Suboxone too early. Buprenorphine is a partial agonist with extremely high receptor affinity but lower intrinsic activity than oxycodone 3, 4. When administered while oxycodone still occupies receptors, buprenorphine forcibly displaces it, causing precipitated withdrawal—an immediate, severe withdrawal syndrome that is:

  • More intense than natural withdrawal
  • Extremely distressing for patients
  • A common cause of treatment dropout
  • Preventable by waiting for objective withdrawal signs

The naloxone component in Suboxone is minimally absorbed sublingually and primarily deters IV misuse 5, 4. However, some patients may experience adverse effects from naloxone absorption, though this is uncommon 6.

Special Considerations

Extended-release oxycodone: If the patient was taking long-acting formulations, wait longer (24-48 hours) as these have prolonged half-lives and delayed withdrawal onset.

Patient education is essential: Explain why waiting is necessary. Patients often fear withdrawal and may pressure for earlier initiation. Emphasize that premature dosing will make them feel significantly worse 1.

Physical dependence vs. addiction: The FDA label distinguishes these 7. Withdrawal management differs for pain patients versus those with opioid use disorder, though the timing principle remains the same.

Related Questions

Is Suboxone (buprenorphine/naloxone) considered an opioid?
What is the appropriate Suboxone (buprenorphine/naloxone) dosing regimen to switch a patient from buprenorphine 6 mg twice daily (total 12 mg per day) to an equivalent regimen?
How should a 20-year-old patient with anemia, dizziness, a history of drug abuse, and current suboxone (buprenorphine/naloxone) therapy be evaluated and managed?
How should I manage a patient already on Suboxone (buprenorphine/naloxone) 8 mg/2 mg three times daily—should the regimen be consolidated to once daily and what maintenance dose is appropriate?
Is it appropriate to take Suboxone (buprenorphine/naloxone) 4 mg twice daily instead of the usual once‑daily regimen?
In a patient with normal vital signs, normal complete blood count, and normal comprehensive metabolic panel, what is the recommended management for a confirmed or strongly suspected pyosalpinx?
What are the drug interactions and monitoring considerations when using isotretinoin, fish‑oil supplements, and atorvastatin together in an adult patient?
In a 51‑year‑old woman presenting with inflamed gums, mild asthma, chronic cough, dyshidrotic eczema, and increased daytime sweating, what is the likely unifying systemic cause and appropriate work‑up and management?
Can a urinary tract infection that is resistant to cefazolin be treated with cephalexin?
When is cefepime indicated for a urinary tract infection and what is the recommended dosing?
What oral antibiotic provides an equivalent spectrum to cefepime?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.